Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Bedfordshire
22 May 2013 17:53



Warwickshire
22 May 2013 17:43



Essex
22 May 2013 17:43


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
markd@zenopa.com
+44 1494 818 049

Testimonials
I've been associated with Zenopa for few months now and since registering I've always found the entire team to be professional and helpful in choosing my new sales position with a private sector compa...
Tushar, 2012

Abbott hits 20m mark for HIV test donations

29 June 2012 15:16 in Medical Company Product News


Abbott has reached the 20 million mark in donations of free rapid HIV tests to people in developing nations, in association with Direct Relief International and the Abbott Fund.

Diagnostic products have been distributed to HIV testing and counselling programmes serving pregnant women and their families in 43 poorer countries, thus helping global efforts to prevent mother-to-child transmission of HIV.

Abbott and the Abbott Fund made the commitment to donate 20 million tests to developing regions back in 2002, with more than 150 partner organisations having been involved in the efforts so far.

As a result, at least 150,000 new cases of HIV have been averted among infants in the last ten years.

Katherine Pickus, divisional vice-president of global citizenship and policy at Abbott and vice-president for the Abbott Fund, said: "Helping pregnant mothers to know their HIV status is a critical step in advancing access to treatment and preventing the transmission of HIV to children."

Abbott is currently in the process of separating into two new companies, with its medical device operations to retain the Abbott name, while its pharmaceuticals division will be rebranded AbbVie.ADNFCR-8000103-ID-801397340-ADNFCR

Other news stories from 29/06/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd